AstraZeneca Market Cap

AstraZeneca has a market cap or net worth of $229.50 billion as of February 24, 2025. Its market cap has increased by 23.39% in one year.

Market Cap

229.50B

Enterprise Value

254.76B

Revenue

54.07B

Ranking

n/a

PE Ratio

32.62

Stock Price

$142.40

Market Cap Chart

Since May 28, 1993, AstraZeneca's market cap has increased from 7.10B to 229.50B, an increase of 3,131.91%. That is a compound annual growth rate of 11.57%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	229.50B	12.96%
Dec 31, 2024	203.17B	-2.91%
Dec 29, 2023	209.27B	-0.08%
Dec 30, 2022	209.44B	15.06%
Dec 31, 2021	182.03B	38.68%
Dec 31, 2020	131.26B	-0.69%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Endo Inc.	2.19B
SS Innovations International	1.72B
Nika Pharmaceuticals	1.02B
Veradigm	864.81M
Elite Pharmaceuticals	520.73M
Glass House Brands	497.07M
CytoDyn	367.12M
Northwest Biotherapeutics	326.95M

Market Cap Rankings